MediWound Announces CEO Transition
Ofer Gonen, current Board member and CEO of Clal Biotechnology Industries Ltd., appointed as New CEO – Effective June 30 Will replace current CEO Sharon Malka, who will join the Board of Directors ...
- Supported exchanges /
- TA /
- CBI.TA
Clal Biotechnology Industries Ltd (CBI TA) stock market data APIs
ILA35
-0.9(-2.5%)
as of November 21, 2024
Price chart is built with Anychart
Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical; incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. It prefers to invest in life sciences, medical devices, biopharmaceutical technologies, and biotechnology companies. The firm seeks to invest in companies based in United States, and Israel. It takes a seat on the board of directors of the companies it invests in. It invests through personal capital of its management. The firm acts as a lead investor and major shareholder in its portfolio companies. Clal Biotechnology Industries Ltd. was founded in July, 1998 and is based in Tel Aviv, Israel with an additional offices in Boston, Massachusetts and Cambridge, Massachusetts. It operates as a former subsidiary of Clal Industries and Investments Ltd.
Clal Biotechnology Industries Ltd Financial Data Overview
| 35.9 | |
| 35 | |
| - | |
| 36.5 | |
| 35 | |
| 29-53 | |
| 56 308 K | |
| 157 M | |
| 32 000 | |
| -0.11 | |
| 0.716 |
Our easy-to-use no-coding solutions help you get the data effortlessly:
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
General: {
Code:
'CBI',
Type:
'Common Stock',
Name:
'Clal Biotechnology Industries Ltd',
Exchange:
'TA',
CurrencyCode:
'ILA',
CurrencyName:
'Israeli Agora',
CurrencySymbol:
'ILA',
CountryName:
'Israel',
CountryISO:
'Il',
OpenFigi:
NULL,
ISIN:
'IL0011042806',
CIK:
NULL,
EmployerIdNumber:
'',
FiscalYearEnd:
'December',
IPODate:
'2007-06-03',
InternationalDomestic:
'International',
Sector:
'Healthcare',
Industry:
'Biotechnology',
}
Clal Biotechnology Industries Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 32 000
- EBITDA -8 064 000
- Earnings Per Share -0.48
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Clal Biotechnology Industries Ltd Earnings via APIs
- Latest Release 2020-11-19
- EPS/Forecast NaN
Get Clal Biotechnology Industries Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Get Clal Biotechnology Industries Ltd latest news via APIs
MediWound Announces CEO Transition
MediWound Ltd. Ofer Gonen, current Board member and CEO of Clal Biotechnology Industries Ltd., appointed as New CEO – Effective June 30 Will replace current CEO Sharon Malka, who will join the Boa...
- BIOPHARMACEUTICAL COMPANY
- CHIEF EXECUTIVE OFFICER
- CLAL BIOTECHNOLOGY INDUSTRIES
- LTD
- MEDIWOUND
- MEDIWOUND LTD
- NASDAQ
- OFER GONEN
- SHARON MALKA
- THE COMPANY
- TISSUE REPAIR
Do you have any questions?
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
